Brief: Claris Lifesciences gets ANDA approval for Bupivacaine Injection
26/07/2016 07:49
July 26 (Reuters) - Claris Lifesciences Ltd CLAI.BO : * Claris receives ANDA approval for Bupivacaine Injection * Source text: http://bit.ly/29WmWxO * Further company coverage CLAI.BO ((Bengaluru Newsroom; +91 80 6749 1130))
Recent news on Telogica
See all newsBrief: Aishwarya Technologies And Telecom Approves Resignation Of G. Amulya As CFO
Brief: Aishwarya Technologies and Telecom gets shareholders' nod to reappoint G Rama Manohar Reddy as MD
Brief: Aishwarya Technologies & Telecom seeks shareholders' nod for reappointing G. Rama Manohar Reddy as MD
U.S. FTC approves Baxter's acquisition of Claris business with condition
Brief: Claris Lifesciences June-qtr consol profit up about 14 pct